Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
JAMA|September 7, 1984
Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infectionG J Mertz, C W Critchlow, J Benedetti, et al.
JAMA|April 27, 1984
Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trialR C Reichman, G J Badger, G J Mertz, et al.
Antiviral Research|April 25, 2000
Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies. The ACTG 187 and 199 study teamsG D Morse, R C Reichman, M A Fischl, et al.
AIDS (London, England)|July 1, 1995
The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudineM A Jacobson, V De Gruttola, M Reddy, et al.
The New England Journal of Medicine|April 15, 1990
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious DiseasesP A Volberding, S W Lagakos, M A Koch, et al.
JAMA|August 10, 1994
The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials GroupP A Volberding, S W Lagakos, J M Grimes, et al.
The American Journal of Medicine|July 20, 1982
Controlled trial of oral acyclovir in the therapy of recurrent herpes simplex genitalis. A preliminary reportR C Reichman, M Ginsberg, E Barrett-Connor, et al.
The New England Journal of Medicine|April 18, 1996
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials GroupA C Collier, R W Coombs, D A Schoenfeld, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|October 13, 1998
Phase I study of atevirdine mesylate (U-87201E) monotherapy in HIV-1-infected patientsL M Demeter, P M Meehan, G Morse, et al.
The Journal of Infectious Diseases|April 14, 2000
Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol TeamC A Benson, P L Williams, D L Cohn, et al.
Pageof 8